{"id":"NCT02523196","sponsor":"University of Colorado, Denver","briefTitle":"Correlation and Comparison of the HepQuant® Disease Severity Index (DSI) With Hepatic Venous Pressure Gradient (HVPG)","officialTitle":"Correlation and Comparison of the HepQuant® Disease Severity Index (DSI) With Hepatic Venous Pressure Gradient (HVPG)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-03","primaryCompletion":"2017-02-23","completion":"2017-02-23","firstPosted":"2015-08-14","resultsPosted":"2021-02-05","lastUpdate":"2021-08-09"},"enrollment":20,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"DIAGNOSTIC"},"conditions":["Liver Disease"],"interventions":[{"type":"DRUG","name":"HepQuant-SHUNT (Drug and Device) #65,123 (4D-cholate) and IND #65,121 (13C-cholate)","otherNames":["HQ-SHUNT"]},{"type":"DEVICE","name":"Hepatic Venous Pressure Gradient (HVPG)","otherNames":["(HVPG)"]}],"arms":[{"label":"(HVPG) and HepQuant-SHUNT (HQ-Shunt)","type":"OTHER"}],"summary":"This study plans to learn more about a new test to look at liver function, the HepQuant-Shunt (HQ-Shunt). The HQ-Shunt is being evaluated for safety and effectiveness as an alternative to Hepatic Venous Pressure Gradient testing in patients with liver disease.","primaryOutcome":{"measure":"Results of HepQuant SHUNT Test: Elimination Rate (IV Phase 1 Only; Min-1)","timeFrame":"Up to 90 minutes","effectByArm":[{"arm":"HVPG <6 mmHg","deltaMin":0.104,"sd":0.017},{"arm":"HVPG ≥6 mmHg","deltaMin":0.092,"sd":0.023},{"arm":"All Patients","deltaMin":0.099,"sd":0.02}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":9},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["22030902"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":20},"commonTop":[]}}